101 related articles for article (PubMed ID: 1423851)
41. Regulation and metabolic role of phospholipase D activity in human thyroid and cultured dog thyrocytes.
Lejeune C; Taton M; Collyn L; Rocmans P; Dumont JE; Mockel J
J Clin Endocrinol Metab; 1996 Oct; 81(10):3526-34. PubMed ID: 8855796
[TBL] [Abstract][Full Text] [Related]
42. Prolonged activation of phospholipase D in Chinese hamster ovary cells expressing platelet-activating-factor receptor lacking cytoplasmic C-terminal tail.
Liu B; Nakashima S; Adachi T; Ito Y; Takano T; Shimizu T; Nozawa Y
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):239-44. PubMed ID: 9355758
[TBL] [Abstract][Full Text] [Related]
43. Synergistic activation of phospholipase D by protein kinase C- and G-protein-mediated pathways in streptolysin O-permeabilized HL60 cells.
Geny B; Cockcroft S
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):531-8. PubMed ID: 1599436
[TBL] [Abstract][Full Text] [Related]
44. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells.
Jeng AY; Lichti U; Strickland JE; Blumberg PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5714-21. PubMed ID: 3931907
[TBL] [Abstract][Full Text] [Related]
45. Phorbol ester tumor promoter affects the mouse epidermal gap junctions.
Kalimi GH; Sirsat SM
Cancer Lett; 1984 Apr; 22(3):343-50. PubMed ID: 6713375
[TBL] [Abstract][Full Text] [Related]
46. v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters.
Song J; Foster DA
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):711-7. PubMed ID: 8379928
[TBL] [Abstract][Full Text] [Related]
47. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
[TBL] [Abstract][Full Text] [Related]
48. Possible involvement of reorganization of actin filaments, induced by tumor-promoting phorbol esters, in changes in colony shape and enhancement of proliferation of cultured epithelial cells.
Sastrodihardjo S; Sasaki Y; Shiba Y; Kanno Y
J Cell Physiol; 1987 Jul; 132(1):49-56. PubMed ID: 3036893
[TBL] [Abstract][Full Text] [Related]
49. Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets.
Lee JC; Kundu JK; Hwang DM; Na HK; Surh YJ
Carcinogenesis; 2007 Jul; 28(7):1491-8. PubMed ID: 17372274
[TBL] [Abstract][Full Text] [Related]
50. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters.
Wei H; Frenkel K
Carcinogenesis; 1993 Jun; 14(6):1195-201. PubMed ID: 8508507
[TBL] [Abstract][Full Text] [Related]
51. Phorbol ester activation of phospholipase D in human monocytes but not peripheral blood lymphocytes.
Kinsky SC; Loader JE; Benedict SH
Biochem Biophys Res Commun; 1989 Jul; 162(2):788-93. PubMed ID: 2787990
[TBL] [Abstract][Full Text] [Related]
52. Substrate selectivity of phospholipase D in HL60 granulocytes: effects of fatty acid supplementation.
Heung YM; Postle AD
Biochem Soc Trans; 1995 May; 23(2):276S. PubMed ID: 7672302
[No Abstract] [Full Text] [Related]
53. The molecular selectivity of phospholipase D in HL60 granulocytes.
Heung YM; Postle AD
FEBS Lett; 1995 May; 364(3):250-4. PubMed ID: 7758577
[TBL] [Abstract][Full Text] [Related]
54. Phorbol esters stimulate a phospholipase D-catalysed reaction with both ester- and ether-linked phospholipids in HeLa cells.
Hii CS; Kokke YS; Pruimboom W; Murray AW
FEBS Lett; 1989 Oct; 257(1):35-7. PubMed ID: 2806563
[TBL] [Abstract][Full Text] [Related]
55. Hydrogen peroxide formation and DNA base modification by tumor promoter-activated polymorphonuclear leukocytes.
Frenkel K; Chrzan K
Carcinogenesis; 1987 Mar; 8(3):455-60. PubMed ID: 3815740
[TBL] [Abstract][Full Text] [Related]
56. Phospholipase D, tumor promoters, proliferation and prostaglandins.
Daniel LW; Sciorra VA; Ghosh S
Biochim Biophys Acta; 1999 Jul; 1439(2):265-76. PubMed ID: 10425400
[TBL] [Abstract][Full Text] [Related]
57. Differential effects of phorbol ester tumor promoters on 3-methylcholanthrene-induced epithelial and mesenchymal skin tumorigenesis.
Bhisey RA; Ramchandani AG; Veturkar PL; Borges AM; Notani PN; Sirsat SM
J Cancer Res Clin Oncol; 1988; 114(3):279-82. PubMed ID: 3384843
[TBL] [Abstract][Full Text] [Related]
58. Phospholipase D activation by the mitogens platelet-derived growth factor and 12-O-tetradecanoylphorbol 13-acetate in NIH-3T3 cells.
Ben-Av P; Liscovitch M
FEBS Lett; 1989 Dec; 259(1):64-6. PubMed ID: 2599112
[TBL] [Abstract][Full Text] [Related]
59. Enhancement of bovine papillomavirus-induced cell transformation by tumour promoters.
Tsang SS; Stich HF
Cancer Lett; 1988 Dec; 43(1-2):93-8. PubMed ID: 2849505
[TBL] [Abstract][Full Text] [Related]
60. Protein kinase C-activating tumor promoters enhance the differentiation of astrocytes in aggregating fetal brain cell cultures.
Honegger P
J Neurochem; 1986 May; 46(5):1561-6. PubMed ID: 2870134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
